These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 31978780)

  • 61. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo.
    Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B
    Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthetic 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidin-4-ones exhibit selective in vitro antitumoral activity and inhibit cancer cell growth in a preclinical model of glioblastoma multiforme.
    da Silveira EF; Azambuja JH; de Carvalho TR; Kunzler A; da Silva DS; Teixeira FC; Rodrigues R; Beira FT; de Cássia Sant Anna Alves R; Spanevello RM; Cunico W; Stefanello FM; Horn AP; Braganhol E
    Chem Biol Interact; 2017 Mar; 266():1-9. PubMed ID: 28174097
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.
    Higuchi F; Fink AL; Kiyokawa J; Miller JJ; Koerner MVA; Cahill DP; Wakimoto H
    Mol Cancer Ther; 2018 Dec; 17(12):2551-2563. PubMed ID: 30217967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.
    Sun H; Zheng X; Zhou Y; Zhu W; Ou Y; Shu M; Gao X; Leng T; Qiu P; Yan G
    Steroids; 2013 Oct; 78(10):1041-5. PubMed ID: 23831782
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo.
    Sun J; Zhang Y; Zhen Y; Cui J; Hu G; Lin Y
    Oncol Rep; 2019 Dec; 42(6):2345-2354. PubMed ID: 31638254
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
    J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of Novel
    Zhang M; Ding Y; Gao M; Lu X; Tan J; Yu F; Gu C; Gu L; Ren X; Hao C; Ming L; Xu K; Mao W; Jin Y; Zhang M; You L; Wang Z; Sun Y; Jiang J; Yang Y; Zhang D; Tang X
    J Med Chem; 2024 Mar; 67(5):3909-3934. PubMed ID: 38377560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional drug screening assay reveals potential glioma therapeutics.
    Badr CE; Wurdinger T; Tannous BA
    Assay Drug Dev Technol; 2011 Jun; 9(3):281-9. PubMed ID: 21184646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis.
    Horne EA; Diaz P; Cimino PJ; Jung E; Xu C; Hamel E; Wagenbach M; Kumasaka D; Wageling NB; Azorín DD; Winkler F; Wordeman LG; Holland EC; Stella N
    Neurooncol Adv; 2021; 3(1):vdaa165. PubMed ID: 33506204
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Machine learning in neuro-oncology: toward novel development fields.
    Di Nunno V; Fordellone M; Minniti G; Asioli S; Conti A; Mazzatenta D; Balestrini D; Chiodini P; Agati R; Tonon C; Tosoni A; Gatto L; Bartolini S; Lodi R; Franceschi E
    J Neurooncol; 2022 Sep; 159(2):333-346. PubMed ID: 35761160
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

  • 75. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
    Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Small Molecules of Marine Origin as Potential Anti-Glioma Agents.
    Alves A; Costa P; Pinto M; Ferreira D; Correia-da-Silva M
    Molecules; 2021 May; 26(9):. PubMed ID: 34063013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficient identification of novel anti-glioma lead compounds by machine learning models.
    Neves BJ; Agnes JP; Gomes MDN; Henriques Donza MR; Gonçalves RM; Delgobo M; Ribeiro de Souza Neto L; Senger MR; Silva-Junior FP; Ferreira SB; Zanotto-Filho A; Andrade CH
    Eur J Med Chem; 2020 Mar; 189():111981. PubMed ID: 31978780
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.